The Efficacy of Steroid Therapy in Vestibular Neuritis
NCT02098330 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2019-01-10
Summary
The purpose of this study was to compare the treatment effectiveness of steroid therapy for vestibular neuritis by using video head impulse test.
Conditions
- Vestibular Neuritis
Interventions
- DRUG
-
Ginkgo biloba & Methylprednisolone
Ginkgo biloba 160 mg/day (per oral, 80 mg twice a day) for 1 month. Methylprednisolone 48 mg/day(per oral, once a day for first 9 days. And then methylprednisolone tapering was started every 2 days. The entire duration of methylprednisolone treatment was 14 days.
- DRUG
-
Ginkgo biloba
Ginkgo biloba 160 mg/day (per oral, 80 mg twice a day) for 1 month.
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Hong Ju Park, Professor · Asan Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2014-12-31
- Completion
- 2015-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Different Dosing Regimens of STOP-AST
NCT06124703 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
NCT06001593 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
NCT03587701 ·Status: RECRUITING ·Phase: PHASE2
-
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
NCT05328895 ·Status: COMPLETED ·Phase: NA
-
Sudden Hearing Loss Multi-center Clinical Trial
NCT02026479 ·Status: UNKNOWN ·Phase: NA
-
Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease
NCT05355610 ·Status: UNKNOWN ·Phase: NA
-
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
NCT06544590 ·Status: COMPLETED
-
Intracochlear Injection of Glucocorticoid
NCT07134075 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
OTO-104 for Meniere's Disease
NCT01084525 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease
NCT06765993 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Stress Management Therapy for Meniere's Disease
NCT01099046 ·Status: UNKNOWN ·Phase: NA
-
Acceleration of the Kinetics of Diffusion of Gadolinium in the Perilymphatic Structures of the Inner Ear.
NCT04949321 ·Status: UNKNOWN ·Phase: NA
-
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT02612337 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing Loss
NCT06968507 ·Status: RECRUITING ·Phase: PHASE4
-
Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets
NCT02718846 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness
NCT01460121 ·Status: COMPLETED ·Phase: NA
-
Intralesional Steroid Injection Versus Voice Therapy in Management of Vocal Nodules
NCT03914092 ·Status: COMPLETED ·Phase: PHASE4
-
Sudden Deafness Treatment Trial
NCT00097448 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Noise-induced Hearing Loss
NCT02049073 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Intratympanic Steroids for Sudden Hearing Loss
NCT04129697 ·Status: UNKNOWN ·Phase: NA
-
Ventilation Tube Insertion for Unilateral Menière's Disease
NCT04835688 ·Status: UNKNOWN ·Phase: NA
-
OTO-104 for the Treatment of Meniere's Disease
NCT01412177 ·Status: COMPLETED ·Phase: PHASE2
-
Prognosis of Vestibular Dysfunction in Patients With Idiopathic Sudden Sensorineural Hearing Loss
NCT03951584 ·Status: COMPLETED
-
Video HIT in Sudden Sensorineural Hearing Loss
NCT04224909 ·Status: UNKNOWN
-
Treatment of Meniere's Disease With Migraine Medications
NCT05582837 ·Status: RECRUITING ·Phase: PHASE4